A Paediatric HIV Roundtable with Industry was organized by DNDi in Dakar, Senegal on 24 October 2013 following the Conference on PADO organized by the WHO. The Roundtable brought together researchers, paediatricians, pharmacologists, regulatory representatives, NGOs, policy makers, funders from the PADO meeting and industry to identify ways to collaborate to expedite the urgent development of paediatric ARV formulations adapted to the needs of children in resource-poor settings. The outcome was a joint call to action. This report summarises the discussion and includes the joint call to action.